Researchers at the Foundation have uncovered new insights into the complex link between dopamine and rest tremor in Parkinson ...

Centogene NV and ROPAD consortium publish data from a landmark study identifying genetic variants that may respond to ...

A study from the University of Arizona shows that the protein PNA5 helps protect brain cells, offering a promising avenue for ...

Nov. 12, 2024 — Researchers have identified a potential biomarker of Parkinson's disease progression. According to the new study, patients with a slow progression of ... Oct. 8, 2024 ...

By Dr. Chinta Sidharthan Sensor data from wearable devices analyzed over five years reveals walking and posture differences ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

Exidavnemab is being developed as a potential disease-modifying treatment, aiming to halt or slow the progression of ...

Monday said Phase 3 TEMPO-2 study evaluating tavapadon in early Parkinson's disease met its primary goal. In the ...

When Denver artist Tim McKay was diagnosed with Parkinson’s disease last year, he made a quick decision: He would document ...

Exidavnemab is a monoclonal antibody designed to eliminate aggregated clumps of the protein biomarker and slow progression of Parkinson's disease.

The company is hoping to show GT-02287 can slow Parkinson's progression by restoring function of GCase, an enzyme encoded by ...